doi: 10.1111/j.2042-7158.1987.tb05126.x.
Biodegradable microspheres: polyacryl starch microparticles as a delivery system for the antileishmanial drug, sodium stibogluconate
Affiliations
- PMID: 2891821
- DOI: 10.1111/j.2042-7158.1987.tb05126.x
Item in Clipboard
Biodegradable microspheres: polyacryl starch microparticles as a delivery system for the antileishmanial drug, sodium stibogluconate
J Pharm Pharmacol.
1987 Oct.
Abstract
Liver parasite burdens of Leishmania donovani in the mouse have been determined after treatment with intravenous administration of sodium stibogluconate in the free or carrier form. The carrier form, in which the drug was covalently bound to polyacryl starch microparticles, was up to 100x more effective than the free form in this murine model of visceral leishmaniasis. Empty microparticles had no effect on liver parasite burdens and the enhanced in-vivo antileishmanial activity of the carrier form of the drug was apparently due to passive drug delivery to the infected liver.
Similar articles
-
Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis.J Pharm Pharmacol. 1988 Mar;40(3):161-5. doi: 10.1111/j.2042-7158.1988.tb05210.x. J Pharm Pharmacol. 1988. PMID: 2899143
-
Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate.J Pharm Pharmacol. 1986 Jul;38(7):502-5. doi: 10.1111/j.2042-7158.1986.tb04623.x. J Pharm Pharmacol. 1986. PMID: 2875149
-
Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani.Antimicrob Agents Chemother. 2001 Dec;45(12):3555-9. doi: 10.1128/AAC.45.12.3555-3559.2001. Antimicrob Agents Chemother. 2001. PMID: 11709339 Free PMC article.
-
Visceral leishmaniasis: drug carrier system characteristics and the ability to clear parasites from the liver, spleen and bone marrow in Leishmania donovani infected BALB/c mice.J Pharm Pharmacol. 1989 Feb;41(2):87-91. doi: 10.1111/j.2042-7158.1989.tb06399.x. J Pharm Pharmacol. 1989. PMID: 2568434
-
Drug targeting in Leishmania donovani infections using tuftsin-bearing liposomes as drug vehicles.FEBS Lett. 1989 Mar 13;245(1-2):204-8. doi: 10.1016/0014-5793(89)80222-4. FEBS Lett. 1989. PMID: 2538359
Cited by
-
Liposomes and nanoparticles as vehicles for antibiotics.Infection. 1991;19 Suppl 4:S224-8. doi: 10.1007/BF01644038. Infection. 1991. PMID: 1879957 Review.
-
Interferon-gamma in starch microparticles: nitric oxide-generating activity in vitro and antileishmanial effect in mice.Pharm Res. 1993 Jun;10(6):783-90. doi: 10.1023/a:1018936522266. Pharm Res. 1993. PMID: 8321846
-
Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs.Parasitol Res. 2003 Jun;90 Suppl 2:S63-70. doi: 10.1007/s00436-002-0769-2. Epub 2002 Dec 11. Parasitol Res. 2003. PMID: 12937968 Review.
-
Progress in antileishmanial drugs: Mechanisms, challenges, and prospects.PLoS Negl Trop Dis. 2025 Jan 3;19(1):e0012735. doi: 10.1371/journal.pntd.0012735. eCollection 2025 Jan. PLoS Negl Trop Dis. 2025. PMID: 39752369 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
